Rapid Critical Metals (RLL:AU) has announced RCM to Acquire Webbs Consol Silver Project from Lode Res.
Download the PDF here.
This post appeared first on investingnews.com
Artificial intelligence (AI) stocks saw continued pressure this week as concerns about overvaluation weighed on the sector ahead of NVIDIA’s (NASDAQ:NVDA) results release for its second fiscal quarter.
The company beat Wall Street projections on revenue, earnings and profits, but shares still fell in extended trading on Tuesday (August 26) after it reported no H20 sales to China, where competition from domestic firms is heating up.
John Murillo, chief business officer at B2BROKER, suggested the pullback could present a short-term buying opportunity for high-quality names with strong fundamentals, but cautioned that it could be the start of a broader correction.
Reports that DeepSeek will train its newest AI models on Huawei chips and Cambricon Technologies’ (SHA:688256) 4,300 percent revenue surge underscore the shifting AI landscape. Still, optimism wasn’t absent: NVIDIA CEO Jensen Huang pointed to accelerating global demand and unveiled a US$60 billion buyback program to reassure investors.
“All in all, the sector’s long-term trajectory remains bullish, with AI adoption accelerating across industries,” said Murillo.
Nasdaq Composite, NVIDIA and Dell Technologies performance, August 26 to 29, 2025.
Chart via Google Finance.
However, it wasn’t enough to reassure the public, and NVIDIA’s share price fell over 4 percent between Wednesday (August 27) and Friday (August 29). As investors analyzed new inflation data that indicates tariffs are impacting prices, other AI-related stocks saw losses too, pulling the S&P 500 (INDEXSP:.INX) from its recent record highs.
With that, here’s a look at some of the other drivers that shaped the tech sector this week.
1. Intel warns of adverse reactions to government equity stake
In a US Securities and Exchange Commission Form 8-K filing dated August 22, Intel (NASDAQ:INTC) warns that the federal government’s 10 percent stake in its business could cause “adverse reactions,” including litigation from investors, employees, customers, suppliers, partners and foreign governments.
The company also discloses a clause in the agreement that would raise the government’s stake to 15 percent if the company fails to meet set manufacturing thresholds.
Moreover, the filing states that, if this agreement prompts other government bodies to seek similar stakes, the varied agendas could diminish the voting power of other shareholders.
The comments come after the White House announced last week that it would take a 10 percent stake in the company in a deal worth around US$8.9 billion. On Monday, (August 25), President Donald Trump suggested he might pursue similar agreements with other American companies, posting on Truth Social:
“I will also help those companies that make such lucrative deals with the United States. I love seeing their stock price go up, making the USA RICHER, AND RICHER.”
Meanwhile, White House economic advisor Kevin Hassett told CNBC that the deal is part of a broader strategy to create a sovereign wealth fund that may include additional companies.
Later, during an interview on CNBC’s Squawk Box on Tuesday, Secretary of Commerce Howard Lutnick said Pentagon officials are considering acquiring equity stakes in leading defense contractors such as Lockheed Martin (NYSE:LMT).
2. Apple sets date to reveal fall product lineup
On Tuesday, Apple (NASDAQ:AAPL) invited media members and analysts to its next launch event, which is scheduled for September 9 at 10:00 a.m. PST.
The event, which will be live streamed from the iPhone maker’s campus, is expected to be the venue for the introduction of the new iPhone 17 lineup and updated Apple Watch models.
The new iPhone series is rumored to include four models:
- iPhone 17
- iPhone 17 Pro
- iPhone 17 Pro Max
- A new iPhone 17 Air that will reportedly replace the iPhone 16 Plus. This new model is rumored to be exceptionally thin, potentially as slim as 5.5 millimeters, a major new design direction for Apple.
The new iPhones are also expected to feature a new ‘Liquid Glass’-based interface as part of iOS 26.
According to Bloomberg journalist Mark Gurman, who has a reputation for being one of the most accurate and prolific sources of leaks about Apple’s future products, the company is planning three years of major iPhone redesigns, starting with the September release. Apple’s first foldable iPhone, code-named V68, is slated to arrive in 2026, according to Gurman. Apple’s 2027 ‘iPhone 20’ will feature curved glass edges to complement the upcoming Liquid Glass-based interface for iOS and other operating systems.
3. IBM, AMD to partner on quantum supercomputer
IBM (NYSE:IBM) and Advanced Micro Devices (AMD) (NASDAQ:AMD) said on Tuesday that they plan to collaborate to develop quantum-centric supercomputing.
The two companies, which have each fundamentally advanced the frontiers of quantum hardware and software, AI accelerators, CPUs and GPUs, said they will work together to “develop scalable, open-source platforms that could redefine the future of computing” by combining their strengths in quantum and high-performance computing.
“Quantum computing will simulate the natural world and represent information in an entirely new way,” said Arvind Krishna, chairman and CEO of IBM, adding that the firms’ collaborative efforts will “build a powerful hybrid model that pushes past the limits of traditional computing.”
“We see tremendous opportunities to accelerate discovery and innovation,” said Dr. Lisa Su, chair and CEO of AMD.
In an interview with Axios, Jay Gambetta, IBM’s quantum vice president, said he aims to get fault-tolerant quantum computers, a set of techniques and architectural designs that ensure a computation can proceed accurately even in the presence of errors, “by the end of this decade.”
4. Cost of Meta data center to exceed original estimate
During a cabinet meeting on Tuesday, Trump told reporters that Meta Platforms’ (NASDAQ:META) Louisiana data center will cost the company around US$50 billion to build.
That’s over 70 percent of the company’s projected CAPEX spending in its latest quarterly report.
“When they said US$50 billion for a plant, I said, ‘What the hell kind of plant is that?’” said Trump, revealing a photo of the proposed data center, Hyperion, superimposed over the island of Manhattan.
“When you look at this, you understand why it’s US$50 billion,” he added.
When the data center was announced, officials in Louisiana estimated the project would cost around US$10 billion. Meta has not confirmed this new estimate and declined to comment on Trump’s remarks.
5. Fusion developer raises US$863 million for energy development
On Thursday (August 28), Commonwealth Fusion Systems, a leading nuclear fusion developer in the US, announced it has secured US$863 million in an oversubscribed Series B2 funding round.
Investors including Morgan Stanley (NYSE:MS) and NVIDIA contributed to this capital raise, which will facilitate the completion of Commonwealth’s Spac fusion demonstration machine, as well as the commencement of construction on a new ARC power plant in Virginia.
“Investors recognize that CFS is making fusion power a reality. They see that we are executing and delivering on our objectives,” said the company’s CEO and co-founder, Bob Mumgaard. “This funding recognizes CFS’ leadership role in developing a new technology that promises to be a reliable source of clean, almost limitless energy — and will enable investors to have the opportunity to capitalize on the birth of a new global industry.”
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
Here’s a quick recap of the crypto landscape for Friday (August 29) as of 9:00 p.m. (UTC).
Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.
Bitcoin and Ethereum price update
Bitcoin (BTC) was priced at US$108,292, a 3.2 percent decrease in 24 hours. It opened at its highest valuation of the day, US$110,473. Its lowest valuation today was US$108,107.
Bitcoin price performance, August 29, 2025.
Chart via TradingView.
Bitcoin’s slip below the US$110,000 threshold stoked fears of a broader crypto market correction on Friday as liquidations doubled, the US Federal Reserve’s preferred inflation gauge showed persistent price pressures, and Bitcoin flashed a potential risk pattern. Analysts warned the token could be edging toward bear market territory.
According to analyst Rekt Capital, BTC needs to regain US$114,000 as support to prevent an extended correction period.
Adding to volatility, a long-dormant Bitcoin whale that resurfaced this month — after buying US$2.5 billion in Ethereum — shifted another US$1.1 billion on Friday.
Ether (ETH) was priced at US$4,345.17, down by 2.3 percent over the past 24 hours. Its highest valuation today was US$4,389.08, and its lowest was US$4,279.96.
Altcoin price update
- Solana (SOL) was priced at US$203.21, down by 3.5 percent over 24 hours. Its lowest valuation on Friday was US$201.61, and its highest valuation was US$211.02.
- XRP was trading for US$2.82, down by 4.4 percent in the past 24 hours. Its lowest valuation of the day was US$2.80, and its highest was US$2.87.
- SUI (Sui) was trading for US$3.26, down by 4.8 percent in the past 24 hours. Its lowest valuation of the day was US$3.22, and its highest level of the day was US$3.35.
- Cardano (ADA) was priced at US$0.8204, down by 3.1 percent. Its lowest valuation for Friday was US$0.8131, and its highest valuation was US$0.8314.
Today’s crypto news to know
Stablecoins cross US$283 billion threshold record
The stablecoin market reached a new milestone on Friday as total supply climbing to $282.8 billion, according to data from DefiLlama. That marks a 128 percent increase since January, driven by stronger demand for dollar-pegged tokens and fresh regulatory clarity in the US. The surge also follows passage of the GENIUS Act, which sets out federal guidelines for stablecoin issuers and has been billed as a growth catalyst within the sector.
Analysts say stablecoins now serve as a “distribution channel” for US dollars, powering cross-border payments and on-chain settlement systems.
Trump-linked miner American Bitcoin targets September Nasdaq listing
American Bitcoin, a mining company backed by Eric Trump and Donald Trump Jr., is preparing to list on Nasdaq in September following its merger with Gryphon Digital Mining, Reuters reported.
The firm is majority owned by Hut 8 Mining (TSX:HUT,NASAQ:HUT), which controls 80 percent of the business, while the Trump brothers are expected to collectively hold about 19 percent. The company has already raised $220 million to expand its operations and accumulate Bitcoin, adding 215 BTC to its balance sheet as of June.
With Bitcoin trading near US$112,000 this week, that stash is valued at roughly US$24 million.
CEO Asher Genoot said American Bitcoin aims to become one of the largest US mining firms, with backing from high-profile investors including Gemini founders Tyler and Cameron Winklevoss.
Hut 8’s own share price has rallied 29 percent this year. If listed today, American Bitcoin would rank among the top 30 public companies holding Bitcoin in the US.
Eric Trump hails US-China leadership in Bitcoin
Speaking at the BTC Asia conference in Hong Kong, Eric Trump praised China’s influence on the digital asset industry and said the US and Beijing were “leading the way” in shaping Bitcoin’s future.
He credited the Middle East as another fast-moving hub for crypto adoption, while stressing Bitcoin’s ability to unite people across borders and cultures.
The younger Trump also added that his father’s administration had accelerated digital asset policy faster in seven months than the prior decade managed. He described America as “winning the digital revolution” with support from Wall Street institutions, sovereign wealth funds, and retirement investors.
Asked whether Bitcoin would be on the agenda in an upcoming US-China trade meeting, he suggested broader topics would dominate but said he “would certainly love to talk about bitcoin.”
21Shares files for SEI-tracking ETF
Crypto asset manager 21Shares has submitted an S-1 registration statement to the US Securities and Exchange Commission (SEC) for an exchange-traded fund (ETF) that would track the price of SEI.
The proposed ETF would utilize CF Benchmarks, a crypto price index provider, to track SEI’s price using data from multiple crypto exchanges. Coinbase Custody Trust Company is slated to act as the SEI custodian.
SEI is the native token of the SEI network, a layer-1 blockchain launched in 2023. The network specializes in trading infrastructure for decentralized exchanges and marketplaces, using the SEI token for network gas fees and governance participation. 21Shares is also exploring the possibility of staking SEI to generate additional returns, though the firm noted in its filing that it is still investigating potential ‘undue legal, regulatory or tax risk’ associated with this practice.
In an X post, 21Shares said the ETF filing is a “key milestone in our vision to expand exchange-traded access to the SEI Network.” US digital asset investment firm Canary Capital also applied for an SEI ETF in April.
Bloomberg’s James Seyffart has listed all 92 crypto ETPs filings and applications awaiting SEC decisions.
US Department of Commerce to publish economic data onchain
The US Department of Commerce (DOC) announced on Wednesday (August 27) that it will begin publishing official economic data on at least nine public blockchains.
Its stated goal is to make vital information immutable and tamper-proof.
In a significant move for the industry that further underscores the potential of decentralized technology to improve governmental operations, the department is collaborating with blockchain data providers Chainlink and Pyth Network to serve as a bridge across various networks, including Bitcoin, Ethereum and Avalanche.
Chainlink will supply data feeds from the Bureau of Economic Analysis, while Pyth will publish GDP data. The DOC will also publish the Personal Consumption Expenditures Price Index and Real Final Sales to Private Domestic Purchasers.
Reports also indicate that exchanges like Coinbase Global (NASDAQ:COIN), Gemini and Kraken helped facilitate the process by assisting with the transactions required to publish the data on-chain.
Aave protocol’s total value locked surges past US$40 billion
While the DOC’s announcement is a major positive for the entire crypto space, the Aave protocol has seen a remarkable surge in its total value locked, exceeding US$40 billion. This comes after the lending platform launched the Horizon RWA Market on Tuesday (August 26), the first real-world application of its ongoing V4 upgrade strategy.
Crypto intelligence platform Nansen also noted the surge in transaction volume on Avalanche this week, with over 11.9 million transactions recorded across over 181,300 active addresses, an increase of 66 percent.
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
Shares of Cameco (TSX:CCO,NYSE:CCJ) were on the rise after the uranium major announced it is reducing its annual production guidance due to expansion delays at the McArthur mine in Saskatchewan, Canada.
Instead of the projected 18 million pounds of U3O8 the company was aiming for from its McArthur River joint venture with Orano, the revised output tally reduces 2025’s production total to between 14 million and 15 million pounds.
In January, Cameco warned that delays at McArthur River — including slower-than-expected ground freezing, development setbacks and labor constraints — could affect its 2025 production outlook.
“We have determined that we are unable to fully mitigate the expected impact of the delayed development and slower than anticipated ground freezing in the first half of 2025,” Cameco’s statement notes.
Strong output from the Cigar Lake mine may help offset the McArthur River delays, the company said, adding that its diversified assets and risk management strategy position it to meet commitments and maintain long-term value.
In total, a strong performance at Cigar Lake could provide an additional 1 million pounds.
The uranium miner offered assurances that it will fulfill all delivery obligations with its customers.
“With favourable market prices for uranium today, we continue to have the option to buy in the spot market if it is advantageous for us to do so,” the company said, noting that it can source material through other means as well.
News of the shortfall sent shares of Cameco higher, with the company rising from C$105.91 on Thursday (August 28) to C$114 during after-trading hours. Values had pulled back to the C$105 range by midday on Friday (August 29).
Broader uranium market challenges
Cameco’s production cut is the second output reduction the sector has seen in as many weeks.
On August 22, Kazatomprom, Kazakhstan’s state-owned uranium producer, reported plans to lower output in 2026, saying that despite firm long-term prices, market conditions don’t support a return to full capacity.
In a corporate update, the company said its production will be about 10 percent lower compared to earlier targets, dropping from 32,777 metric tons of U3O8 to 29,697 metric tons. The reduction, equal to roughly 8 million pounds, or 5 percent of global supply, will largely stem from changes at its Budenovskoye joint venture.
After spiking to triple-digit levels unseen in more than a decade in early 2024, the spot price has been under pressure, falling as low as US$63.36 in March of this year. However, prices have steadily grown since then, reaching a second quarter high of US$79.01 on June 30 and currently holding at the US$75 mark. Kazatomprom notes that while the spot price remains volatile, the long-term uranium price has held steady at around US$80.
The company plans to exercise its option to operate within a 20 percent deviation of its 2026 subsoil use production levels, with formal guidance to come later. The sector major also also reported stable sulfuric acid supply for 2026, easing concerns after last year’s shortages forced a sharp output downgrade. However, its new acid plant won’t be ready until at least 2026, and higher mineral extraction taxes are expected to weigh on costs.
The updates came alongside half-year results showing that net profit was down 54 percent to 263.2 billion tenge (US$489.5 million), while revenue was off 6 percent at 660.2 billion tenge, largely on weaker sales volumes.
Despite lower near-term output, Kazatomprom said it remains committed to exploration in order to replenish its reserves and maintain its dominance as the world’s top uranium supplier.
Beyond market headwinds, the company highlighted Kazakhstan’s nuclear ambitions, with proposals for three domestic reactors that would require about 1.04 million pounds of uranium each year.
Uranium supply shortage unavoidable?
With tightening margins between uranium demand and global mine supply, these latest announcements are likely to impact market sentiment and could push prices higher.
Taking to X, formerly known as Twitter, Uranium Insider’s Justin Huhn posted an ominous message:
You don’t have to know exactly what will disrupt this market, only that the conditions are there for disruption
— Uranium Insider (@uraniuminsider) August 28, 2025
According to the World Nuclear Association, mine supply currently accounts for 90 percent of uranium demand, with the other 10 percent being fulfilled through secondary supply sources.
However, secondary supply is declining and mine supply has not grown to account for the discrepancy. This is likely to be further compounded by the addition of 70 new nuclear reactors that are currently in the construction phase.
Coupled with heightening energy demands from the artificial intelligence sector, analysts at FocusEconomics are projecting a higher spot price environment moving forward.
“The Consensus among our panelists is for uranium prices to remain well above the levels that prevailed in the 2010s for the rest of this decade, with prices forecast to hover between US$65 and US$80 per pound,” the firm wrote in an email. “That said, panelists don’t see a return to the highs of 2024, a period when the spot price likely got ahead of underlying market fundamentals due to investor exuberance.”
Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
About Earthwise Minerals
Earthwise Minerals Corp. (CSE: WISE; FSE: 966) is a Canadian junior exploration company focused on advancing the Iron Range Gold Project in southeastern British Columbia near Creston, B.C. The Company holds an option to earn up to an 80% interest in the fully permitted project, which is road-accessible and situated within a prolific mineralized corridor. The property covers a 10 km x 32 km area along the Iron Range Fault System and hosts multiple high-grade gold showings and large-scale geophysical and geochemical anomalies.
For more information, visit www.earthwiseminerals.com.
EARTHWISE MINERALS CORP.,
ON BEHALF OF THE BOARD
‘Mark Luchinski’
Contact Information:
Mark Luchinski
Chief Executive Officer, Director
Telephone: (604) 506-6201
Email: luch@luchccorp.com
Forward Looking Statements
This news release includes statements that constitute ‘forward-looking information’ as defined under Canadian securities laws (‘forward-looking statements’) including, without limitation, statements respecting the Offering and the intended use of proceeds therefrom. Statements regarding future plans and objectives of the Company are forward looking statements that involve various degrees of risk. Forward-looking statements reflect management’s current views with respect to possible future events and conditions and, by their nature, are subject to known and unknown risks and uncertainties, both general and specific to the Company. Although the Company believes the expectations expressed in its forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and actual outcomes may differ materially from those in forward-looking statements. Additional information regarding the various risks and uncertainties facing the Company are described in greater detail in the ‘Risk Factors’ section of the Company’s annual management’s discussion and analysis and other continuous disclosure documents filed with the Canadian securities regulatory authorities which are available at www.sedarplus.ca. The Company undertakes no obligation to update forward-looking information except as required by applicable law. The reader is cautioned not to place undue reliance on forward-looking statements.
For more information, please contact Mark Luchinski, Chief Executive Officer and Director, at luch@luchccorp.com or (604) 506-6201.
Source
This post appeared first on investingnews.com
Statistics Canada released its second-quarter gross domestic product (GDP) figures on Friday (August 29). The data showed that the Canadian economy shrank 0.4 percent in the second quarter and declined 1.6 percent on an annualized basis. The decrease comes following first-quarter gains of 0.5 percent and a 2 percent annualized increase.
Much of the decrease was attributed to a 7.5 percent drop in exports compared to Q1. Canadian exports had risen 1.4 percent in the first three months of the year as US companies increased imports to get ahead of incoming tariffs.Excluding the lower costs at the pumps, CPI remained steady at 2.5 percent, the same increase as May and June.
On an industry level, new monthly data for June shows that the resource sector grew by 0.1 percent after two months of declines, primarily driven by a 2.6 percent gain in the oil and gas subsector, with oil sands extraction rising 6.4 percent over May. However, gains were offset by a 9.7 percent monthly decline in support activities for the resource sector, its largest drop in five years, led by reduced rigging and drilling activities.
South of the border, the US Bureau of Economic Analysis released its second estimate for Q2 real GDP on Thursday (August 28). The data shows that US GDP grew by 3.3 percent during the quarter, 0.3 percent higher than its advance estimate.
According to the agency, the figure reflects a decrease in imports and an increase in consumer spending. The GDP’s upward momentum was tempered by a 13.8 percent decrease in private domestic investment, marking the most significant decline since 2020, during the pandemic.
The growth follows a 0.5 percent decrease in the first quarter of 2025, which saw a significant rise in imports.
This week also saw US President Donald Trump attempt to remove US Federal Reserve Board of Governors member Lisa Cook. Trump justified the decision based on Federal Housing Finance Agency Director Bill Pulte’s claim that Cook claimed primary residence in two mortgage applications submitted weeks apart in 2021. She was confirmed to the Fed Board of Governors in May 2022.
Cook is fighting the move in court, with her lawyer stating that Trump’s unsubstantiated allegation of an event prior to Cook’s confirmation does not meet the ’cause’ required by the Federal Reserve Act to remove a governor. By the end of the day on Friday, the judge hearing the case did not reach a decision on whether to issue a temporary restraining order that would allow Cook to remain in her role during the case.
Pulte has previously made similar allegations against other prominent Democrats, including California Senator Adam Schiff, a vocal critic of Trump, and New York Attorney General Letitia James, who oversaw a civil suit against Trump that resulted in a US$500 million award.
Trump has been eager to reshape the Federal Reserve Board and has hinted that he would like to replace Chairman Jerome Powell before his term ends in 2026. Trump believes the Fed has not been acting quickly enough to lower interest rates and stimulate the economy.
Markets and commodities react
Canadian equity markets were largely unfazed by Canada’s weak GDP data. In fact, the S&P/TSX Composite Index (INDEXTSI:OSPTX) set a new record on Friday, closing the week up 1.73 percent to 28,564.45. The S&P/TSX Venture Composite Index (INDEXTSI:JX) did even better, climbing 5.36 percent to finish Friday at 829.57. The CSE Composite Index (CSE:CSECOMP) fell 0.45 percent on Friday following the StatsCan release, but gained 4.17 percent overall during the week to 166.9.
US equity markets also posted gains this week, but fell from record highs on Friday following a selloff of tech stocks. The S&P 500 (INDEXSP:INX) was up 1.19 percent to 6,460.25, while the Nasdaq 100 (INDEXNASDAQ:NDX) rose 0.99 percent to 23,415.42. Meanwhile, the Dow Jones Industrial Average (INDEXDJX:.DJI) gained 1.32 percent on the week to 45,631.73.
The gold price gained 3.19 percent this week on expectations of a September rate cut by the Federal Reserve, reaching US$3,448.15 per ounce by 4:00 p.m. EDT on Friday. Silver ended the week with a larger gain of 4.2 percent, nearly crossing the US$40 per ounce mark in morning trading before settling at US$39.74 per ounce.
Copper also saw some upward movement, gaining 1.1 percent to US$4.59 per pound. The S&P GSCI (INDEXSP:SPGSCI) commodities index posted an increase of 1.3 percent by close on Friday, finishing at 549.70.
Top Canadian mining stocks this week
How did mining stocks perform against this backdrop?
Take a look at this week’s five best-performing Canadian mining stocks below.
Stocks data for this article was retrieved at 4:00 p.m. EDT on Friday using TradingView’s stock screener. Only companies trading on the TSX, TSXV and CSE with market caps greater than C$10 million are included. Mineral companies within the non-energy minerals, energy minerals, process industry and producer manufacturing sectors were considered.
1. Trifecta Gold (TSXV:TG)
Weekly gain: 117.24 percent
Market cap: C$23.77 million
Share price: C$0.63
Trifecta Gold is a gold exploration company focused on a portfolio of 11 properties in the Tombstone gold belt in the Yukon, Canada.
Its most advanced is its flagship Mt. Hinton gold-silver project, located near Hecla Mining’s (NYSE:HL) Keno Hill silver mine. The company’s project page indicates that vein float samples collected in January 2023 show grades of up to 273 grams per metric ton (g/t) gold.
The company has also been advancing exploration work at its Rye property, which hosts a gold-bismuth soil anomaly, as well as several gold-rich veins.
Shares in Trifecta rose this week alongside news on Thursday that the company had commenced its inaugural drill program at Rye, completing 970 meters across three holes. The announcement reported that the first hole intersected a high density of sheeted quartz veins.
The company said preliminary rock samples collected from the site earlier in 2025 returned multiple assays with greater than 5 g/t gold, including one highlight with 21.1 g/t gold and 8,550 parts per million (ppm) bismuth.
2. Consolidated Lithium Metals (TSXV:CLM)
Weekly gain: 100 percent
Market cap: C$13.98 million
Share price: C$0.04
Consolidated Lithium is an exploration and development company working to advance a portfolio of hard rock lithium projects in Quebéc, Canada.
Its most advanced asset is the Vallée lithium project, a 75/25 joint venture between Consolidated and Sayona Mining (ASX:SAY,OTCQB:SYAXF). The project is located in the Abitibi Greenstone Belt adjacent to and along strike of Sayona’s and Piedmont Lithium (NASDAQ:PLL) North American Lithium mining operation. According to the company’s project page, the Vallée property hosts multiple lithium-bearing pegmatites over a 1 kilometer strike length.
Consolidated announced on Wednesday (August 27) that it signed a letter of intent with the Government of Quebéc-owned Soquem to earn an 80 percent interest in the Kwyjibo rare earth project, located in the Côte-Nord region of the province.
Under the terms of the letter, Consolidated can earn up to an 80 percent interest in the project through two phases, in return for a combination of cash payments, shares in Consolidated and project investments.
A 2017 preliminary economic assessment for Kwyjibo reports project economics including an after-tax net present value of C$373.9 million and an internal rate of return of 17.8 percent, with a payback period of 3.6 years.
3. Electric Metals (TSXV:EML)
Weekly gain: 68.75 percent
Market cap: C$44.34 million
Share price: C$0.27
Electric Metals is a mineral development company focused on advancing its flagship North Star manganese project in Minnesota, US. According to the company, the asset is North America’s highest-grade manganese resource. It plans to produce high-purity manganese sulphate monohydrate for lithium-ion batteries.
The most recent news from Electric Metals was released on Tuesday, when it announced a preliminary economic assessment for the project. The assessment demonstrated a base-case after-tax net present value of US$1.39 billion, with an internal rate of return of 43.5 percent and a payback period of 23 months. and suggested an average annual after-tax cash flow of US$249.6 million.
The report also included an updated mineral resource estimate with an indicated resource of 7.6 million metric tons of ore grading 19.07 percent manganese, 22.33 percent iron and 30.94 percent silicon, and an inferred resource of 3.73 million metric tons of ore grading 17.04 percent manganese, 19.04 percent iron and 30.03 percent silicon.
4. Sage Potash (TSXV:SAGE)
Weekly gain: 58.33 percent
Market cap: C$31.93 million
Share price: C$0.38
Sage Potash is a potash exploration company currently working to advance its portfolio of mineral holdings in Utah’s Paradox Basin in the US.
Historic oil and gas exploration in the basin dating back a century discovered the potential for the potash beds, but they were too deep for mining methods at the time. Sage has since confirmed their presence through its own exploration.
In a revised technical report from February 2023, the company reported an inferred mineral resource estimate of up to 159.3 million metric tons of in-place sylvinite from the upper potash bed and up to 120.2 million metric tons of sylvinite from the lower potash bed.
On August 14, Sage announced that Stockwell Day had joined the company board. Day served several ministerial roles for the Canadian government under Prime Minister Stephen Harper, including as President of the Treasury Board and Minister of International Trade.
This was followed by news on Wednesday that Day had been granted 600,000 stock options at an exercise price of C$0.30 per share and would remain valid for a period of five years.
Sage’s share price spiked earlier this week after the US Government added potash in its draft of an updated list of critical minerals.
5. Kincora Copper (TSXV:KCC)
Weekly gain: 58.33 percent
Market cap: C$24.8 million
Share price: C$0.095
Kincora Copper is an exploration company operating under a project generator model and partnering with other companies to advance its portfolio, including copper-gold projects in the Macquarie Arc of New South Wales, Australia.
Among them is the Northern Junee-Narromine Belt (NJNB) land package, which is covered by a May 2024 earn-in agreement that could see AngloGold Ashanti (NYSE:AU,JSE:ANG) earn up to an 80 percent interest in the Nyngan and Nevertire licenses through AU$50 million in exploration expenditures or AU$25 million for exploration and the completion of a pre-feasibility study.
Kincora secured a second agreement with AngloGold Ashanti in April for the Nyngan South, Nevertire South and Mulla licenses with similar terms, bringing the total exploration funding to AU$100 million.
On Monday (August 25), Kincora announced results from the first drilling program at the Nyngan project, noting that assays support the potential for porphyry copper and epithermal gold, and that it saw ‘encouraging results at particularly shallow depths’ from drill targets identified by a ground gravity survey earlier this year.
Additionally, Kincora said that drilling is ongoing at the Nevertire South and Nevertire projects, with the initial program planned for seven holes and 2,150 meters.
FAQs for Canadian mining stocks
What is the difference between the TSX and TSXV?
The TSX, or Toronto Stock Exchange, is used by senior companies with larger market caps, and the TSXV, or TSX Venture Exchange, is used by smaller-cap companies. Companies listed on the TSXV can graduate to the senior exchange.
How many mining companies are listed on the TSX and TSXV?
As of May 2025, there were 1,565 companies listed on the TSXV, 910 of which were mining companies. Comparatively, the TSX was home to 1,899 companies, with 181 of those being mining companies.
Together, the TSX and TSXV host around 40 percent of the world’s public mining companies.
How much does it cost to list on the TSXV?
There are a variety of different fees that companies must pay to list on the TSXV, and according to the exchange, they can vary based on the transaction’s nature and complexity. The listing fee alone will most likely cost between C$10,000 to C$70,000. Accounting and auditing fees could rack up between C$25,000 and C$100,000, while legal fees are expected to be over C$75,000 and an underwriters’ commission may hit up to 12 percent.
The exchange lists a handful of other fees and expenses companies can expect, including but not limited to security commission and transfer agency fees, investor relations costs and director and officer liability insurance.
These are all just for the initial listing, of course. There are ongoing expenses once companies are trading, such as sustaining fees and additional listing fees, plus the costs associated with filing regular reports.
How do you trade on the TSXV?
Investors can trade on the TSXV the way they would trade stocks on any exchange. This means they can use a stock broker or an individual investment account to buy and sell shares of TSXV-listed companies during the exchange’s trading hours.
Article by Dean Belder; FAQs by Lauren Kelly.
Securities Disclosure: I, Dean Belder, hold no direct investment interest in any company mentioned in this article.
Securities Disclosure: I, Lauren Kelly, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
The gold price was on the rise this week, breaking through US$3,400 per ounce once again.
It’s been pushed higher by US dollar weakness, as well as Federal Reserve turmoil.
President Donald Trump has been pressuring Fed Chair Jerome Powell to cut interest rates for months, and on Monday (August 25) the situation developed further when Trump posted a letter on his social media platform Truth Social. In it, he said he was removing Lisa Cook from her position on the central bank’s board of governors due to allegations of mortgage fraud.
Cook, who has been voting to hold rates steady, was due to serve until 2038; she has now filed a lawsuit asking for Trump’s order to be declared ‘unlawful and void.’
The move has spurred questions about whether Trump can actually fire her — while the Federal Reserve Act doesn’t allow him to remove Fed officials at will, he can do so ‘for cause.’
For its part, the Fed has said it will abide by any court decision.
The situation is still developing, and gold market watchers are keeping a close eye on how it plays out. The yellow metal tends to fare better when interest rates are low, and some experts believe that a rate cut from the Fed could kick off its next move higher
The Fed’s next meeting is scheduled to run from September 16 to 17. Expectations are high that it will cut rates at that time, even though the latest data shows that its preferred measure of inflation, the personal consumption expenditures (PCE) price index, was up 2.6 percent year-on-year in July.
Core PCE, which excludes food and energy, saw a rise of 2.9 percent.
Bullet briefing — US drafts new critical minerals list, uranium miners make cuts
US drafts new critical minerals list
The US Department of the Interior has released a new draft critical minerals list, and the recommended additions include silver, as well as potash, silicon, copper, rhenium and lead.
Silver’s potential inclusion is turning heads in the mining community as market participants assess the potential impact for the metal. The critical minerals list is designed to guide federal strategy, investment and permitting deals as the US works to lock down supply of key commodities, meaning that silver-focused companies could see benefits such as tax breaks and faster timelines.
In total, the draft list has 54 minerals, with 50 included based on results from an economic effects assessment. Three were selected on the back of a qualitative evaluation, and zirconium is there because of the potential for a single point of failure in the US supply chain.
The list was set up after a 2017 executive order from Trump and is updated every three years.
It’s worth noting that silver and the other recommended additions aren’t officially critical minerals yet — the draft critical minerals list was posted for public comment on Tuesday (August 26), and feedback will be accepted for 30 days. It’s also worth noting that two commodities may be stripped of their critical mineral status — arsenic and tellurium have been recommended for removal.
Critical minerals lists vary from country to country based on individual needs, although in many cases they have similarities. In January 2024, a group of silver industry participants, including many major miners, sent a letter to Canada’s energy and natural resources minister proposing that silver be included in the nation’s critical minerals list; to date, it has not been added.
Uranium miners cut production guidance
Sweden’s government has proposed the removal of the country’s ban on uranium mining as it looks to reduce its reliance on imports of the energy fuel.
Uranium mining has been banned in Sweden since 2018, but the country has six operating reactors and generates around one-third of its power from nuclear energy.
The ban is set to be removed on January 1, 2026, and comes as nations increasingly look to nuclear power to fill their energy needs. It also comes amid supply questions — although demand is rising and prices are out of a years-long slump, miners have been slow to ramp back up post-Fukushima.
Just last week, Kazatomprom said it was lowering its 2026 production target compared to earlier estimates, cutting about 8 million pounds. Although the company sees stability in long-term uranium prices and strong sector fundamentals, it isn’t prepared to return to 100 percent levels.
Cameco (TSX:CCO,NYSE:CCJ) made a similar statement this week, saying its 2025 output will be impacted by delays in transitioning the Saskatchewan-based McArthur River mine to new mining areas. Production will be 4 million to 5 million pounds lower, although there is a chance for Cigar Lake to partially offset that loss.
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
Here’s a quick recap of the crypto landscape for Friday (August 29) as of 12 noon (UTC).
Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.
Bitcoin and Ethereum price update
Bitcoin (BTC) was priced at US$108,747, a 3.3 percent decrease in 24 hours. Its lowest valuation of the day was US$108,198 and its highest price on Friday was US$112,652.
Bitcoin price performance, August 29, 2025.
Chart via TradingView
Bitcoin’s slip below the US$110,000 threshold stoked fears of a broader crypto market correction on Friday as liquidations doubled, the Federal Reserve’s preferred inflation gauge showed persistent price pressures, and Bitcoin flashed a potential risk pattern. Analysts warned the token could be edging toward bear market territory.
Adding to volatility, a long-dormant Bitcoin whale that resurfaced this month—after buying US$2.5 billion in Ethereum—shifted another US$1.1 billion on Friday.
Ether (ETH) was priced at US$4,335.28, down by 3.2 percent over the past 24 hours. Its highest was US$4,511.09 and its lowest was US$4,279.96.
Altcoin price update
- Solana (SOL) was priced at US$204.82, down by 2.4 percent. Its lowest valuation on Friday was US$203.74, and its highest valuation was US$217.66.
- XRP was trading for US$2.94, down by 4.4 percent in the past 24 hours, and at its lowest valuation of the day. Its highest valuation on Wednesday was US$2.98.
- SUI (Sui) was trading for US$3.30, down by 4.3 percent in the past 24 hours. Its lowest valuation of the day was US$3.29, and its highest level of the day was US$3.50.
- Cardano (ADA) was priced at US$0.8201, down by 3.8 percent. Its lowest valuation for Friday was US$0.817, and its highest valuation was US$0.8618.
Today’s crypto news to know
Stablecoins cross US$283 billion threshold record
The stablecoin market reached a new milestone on Friday as total supply climbing to $282.8 billion, according to data from DefiLlama.
That marks a 128 percent increase since January, driven by stronger demand for dollar-pegged tokens and fresh regulatory clarity in the US.
The surge also follows passage of the Genius Act, which sets out federal guidelines for stablecoin issuers and has been billed as a growth catalyst within the sector.
Analysts say stablecoins now serve as a “distribution channel” for US dollars, powering cross-border payments and on-chain settlement systems.
Eric Trump hails US–China leadership in Bitcoin
Speaking at the BTC Asia conference in Hong Kong, Eric Trump praised China’s influence on the digital asset industry and said the US and Beijing were “leading the way” in shaping Bitcoin’s future.
He credited the Middle East as another fast-moving hub for crypto adoption, while stressing Bitcoin’s ability to unite people across borders and cultures.
The younger Trump also added that his father’s administration had accelerated digital asset policy faster in seven months than the prior decade managed. He described America as “winning the digital revolution” with support from Wall Street institutions, sovereign wealth funds, and retirement investors.
Asked whether Bitcoin would be on the agenda in an upcoming US–China trade meeting, he suggested broader topics would dominate but said he “would certainly love to talk about bitcoin.”
Trump-Linked miner American Bitcoin targets September Nasdaq listing
American Bitcoin, a mining company backed by Eric Trump and Donald Trump Jr., is preparing to list on Nasdaq in September following its merger with Gryphon Digital Mining, Reuters reported.
The firm is majority-owned by Hut 8, which controls 80 percent of the business, while the Trump brothers are expected to collectively hold about 19 percent. The company has already raised $220 million to expand its operations and accumulate Bitcoin, adding 215 BTC to its balance sheet as of June.
With Bitcoin trading near US$112,000 this week, that stash is valued at roughly US$24 million.
CEO Asher Genoot said American Bitcoin aims to become one of the largest US mining firms, with backing from high-profile investors including Gemini founders Tyler and Cameron Winklevoss.
Hut 8’s own stock has rallied 29 percent this year. If listed today, American Bitcoin would rank among the top 30 public companies holding Bitcoin in the US.
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on through generations. So what is genetics investing?
When it comes to genetics investing, companies in this niche of the life science sector are mostly focused on four submarkets: DNA sequencing, genetic testing, gene therapy and genomics, which includes gene editing.
This life sciences submarket has gained much attention from investors over the past several years. It has provided a launching pad for a number of biotech firms developing and commercializing novel treatments and drugs addressing a wide range of diseases with unmet needs.
For those looking to dive into the genetics sector, there are numerous investment opportunities to consider. Investing in gene stocks is the most common route, but there are risks due to the market’s volatility, especially when it comes to wins or losses with the US Food and Drug Administration (FDA).
Exchange-traded funds (ETFs) are another popular option for gaining exposure to the industry, and come with less risk than investing in a single stock.
In this article
What are the key areas of the genetics sector?
Before diving into investment opportunities in the genetics market, it’s important to understand the industry and the key areas of genetics mentioned above.
What investors should know about the genetics market
In the biotech sector, gene therapy is one of the more advanced treatment options, and gene therapy pipeline candidates are robust in late-stage clinical trials.
In terms of what will — and already has — disrupted the genetics industry, CRISPR gene-editing technology has been on the rise for quite some time. It uses short repeating DNA sequences with “spacers” dividing them to treat genetic diseases.
While the use of the technology is still in its early stages, in the coming years it’s expected to have a big impact on how genetic diseases are treated, and there are a range of clinical trials underway involving CRISPR technology. So far, the only FDA approved CRISPR-based medicine is Casgevy, developed by Vertex Pharmaceuticals (NASDAQ:VRTX) and CRISPR Therapeutics (NASDAQ:CRSP). It was originally approved in late 2023 for the treatment of sickle cell disease.
The prominence of gene therapies in the life science sector was a major theme at the 2025 JPMorgan Healthcare Conference in January 2025. Peter Marks, then-director of the FDA’s Center for Biological Evaluation and Research, told attendees that his agency is aiming to accelerate approvals for gene therapies.
In 2024, the FDA expanded approvals for CRISPR-based Casgevy to beta-thalassemia, and it also approved Pfizer’s (NYSE:PFE) Beqvez and PTC Therapeutics’ (NASDAQ:PTC) Kebilidi.
Despite experiencing a challenging year in 2024, there is still a lot of optimism in the gene therapy sector. Also speaking at the January conference, Alliance for Regenerative Medicine president Tim Hunt said he believes 10 new cell and gene therapy treatments could reach blockbuster status by 2030.
“No one’s saying there aren’t headwinds, but we are seeing important signs of growth,” he added.
Looking at DNA sequencing, this market is driven by advances in biotech, the increasing prevalence of cancer and rising demand for precision medicine, as well as higher investment in research and development. DNA sequencing has become a vital component of this growth and has played a key role in remodeling molecular biology and genomics research.
Genetic testing is another segment of the genetics industry that is growing at a fast pace. Unsurprisingly, technological breakthroughs have had a huge impact on genetic testing, and so has the fact that governments and regulatory bodies are turning their attention to this market in order to regulate and raise awareness to treat diseases such as cancer, cystic fibrosis and sickle cell anemia.
Biotech and pharmaceutical companies are also expressing interest in this sector, which is expected to further fuel genetics sector growth in the coming years. Mergers and acquisitions activity is also expected to increase as companies seek to expand their product portfolios new candidates and technologies.
As can be seen, the genetics industry is vast and complex, but is also ripe with investment opportunities.
How to invest in gene stocks
Investors looking to invest in the field of genetics through stocks have many options, from large-cap biotech companies to pure-play gene therapy, gene editing and genetic testing stocks.
See the list below for genetics companies to consider, and check out the linked stock lists for more options.
Large-cap gene stocks
There are a number of large-cap biotech companies that have significant focuses on the field of genomics. Here are a few to consider:
Amgen (NASDAQ:AMGN)
A global leader in biotech, Amgen uses advanced human genetics to develop and manufacture therapeutics targeting a variety of diseases with unmet medical needs. The company’s subsidiary deCODE Genetics is researching how human genetic diversity influences disease.
AbbVie (NYSE:ABBV)
Research-based global biopharmaceutical company AbbVie that addresses several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology. AbbVie is collaborating with ADARx Pharmaceuticals to develop siRNA therapeutics, viewed as a promising genetic medicine approach for silencing disease-causing genes.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Regeneron Pharmaceuticals creates medicines for a wide variety of diseases. The Regeneron Genetics Center is conducting one of the world’s largest genetics sequencing efforts in collaboration with health organizations around the world.
Gene editing (CRISPR) stocks
There are a variety of options for investors looking to buy in on the field of gene editing stocks, including:
CRISPR Therapeutics (NASDAQ:CRSP)
CRISPR Therapeutics and its partner Vertex Pharmaceuticals co-developed drug Casgevy, a CRISPR/Cas9 genome-edited cell therapy. Casgevy is the first ever treatment based on CRISPR technology to be approved for the US market, as well as by the European Medicines Agency and Health Canada.
Intellia Therapeutics (NASDAQ:NTLA)
Intellia Therapeutics is a gene editing biotech company developing drugs for patients with genetic and autoimmune diseases. The company’s drug pipeline includes late-stage clinical programs for therapies targeting hereditary angioedema and transthyretin amyloidosis.
Vertex Pharmaceuticals (NASDAQ:VRTX)
Vertex Pharmaceuticals is the other half of the team behind Casgevy. It also offers exposure to other sectors of genomics, with approved treatments for cystic fibrosis and a pipeline of genetic and cell therapies. Its investigational VX-880 islet cell replacement therapy could restore insulin production in patients with type 1 diabetes.
Gene therapy stocks
Gene therapy stocks and stem cell stocks are also popular choices for genetics investing. Here are a few to get you started:
Novartis (NYSE:NVS)
Switzerland-based Novartis is focused on treatments for a wide range of diseases, including cancers, malaria, leprosy and sickle cell disease. Novartis is developing adeno-associated-virus (AAV)-based and CRISPR-based gene therapies. Its Kymriah treatment was the first CAR-T cell therapy to be approved by the FDA, and the agency also approved its AAV-based therapy Zolgensma.
Gilead Sciences (NASDAQ:GILD)
Global biopharmaceutical company Gilead Sciences is advancing breakthrough medicines to prevent and treat serious diseases such as HIV, viral hepatitis and cancer. Its cell-based gene medicine for blood cancer, the CAR T-cell therapy Yescarta, was the second gene therapy approved by FDA.
uniQure (NASDAQ:QURE)
Genomic medicine company uniQure develops and markets gene therapy products for patients with severe genetic diseases. The company’s AAV-based gene therapy platform targets liver-directed and central nervous system disorders.
Genetic testing stocks
For those interested in genetic testing stocks, these three stocks provide a snapshot on different ways to get exposure to the sector:
Exact Sciences (NASDAQ:EXAS)
Exact Sciences focuses on molecular diagnostic tests. The company has developed a molecular screening technology platform called Cologuard that detects a range of cancers, including breast cancer and colorectal cancer.
Fulgent Genetics (NASDAQ:FLGT)
A leader in clinical diagnostic genetic sequencing, Fulgent Genetics is a full-service genomics testing company. Its proprietary technology platform, Picture Genetics, allows for the identification of personal DNA health markers in individual patients.
Illumina (NASDAQ:ILMN)
Illumina develops, manufactures and markets life science tools and integrated systems that enable the implementation of genomic solutions for the healthcare sector. Its focus is on oncology testing, genetic disease testing, reproductive health and research.
How to invest in genomics ETFs
For those who would prefer to invest in the genetics industry overall rather than buying shares in an individual gene stock, investing in genomics ETFs is the way to go. Here are some available ETFs that offer exposure to companies in the biotech and genetics sectors to start you off:
ARK Genomic Revolution ETF (ARCA:ARKG)
This ETF tracks firms focused on CRISPR technology, targeted therapeutics, bioinformatics, molecular diagnostics, stem cells and agricultural biology. Its holdings include CRISPR Therapeutics and Guardant Health (NASDAQ:GH).
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
The Global X Genomics & Biotechnology ETF invests in stocks that are involved in genomic science, which includes gene computational genomics and biotechnology. Its holdings include Illumina and Avidity Biosciences (NASDAQ:RNA).
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA)
The iShares Genomics Immunology and Healthcare ETF focuses on companies involved with genomics, immunology and bioengineering. Its holdings include Regeneron Pharmaceuticals and Arcellx (NASDAQ:ACLX).
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
This post appeared first on investingnews.com
Carbonxt Group (CG1:AU) has announced FY25 Results Announcement
Download the PDF here.
This post appeared first on investingnews.com